We are live on ! Find out more
HLVX

HilleVax

Delisted

HLVX was delisted on the 16th of September, 2025.

1 hedge funds and large institutions have $0 invested in HilleVax in 2025 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 73 closing their positions.

New
Increased
Maintained
Reduced
Closed

82.38% less ownership

Funds ownership: 82.73%0.36% (-82%)

99% less funds holding

Funds holding: 741 (-73)

100% less funds holding in top 10

Funds holding in top 10: 50 (-5)

100% less capital invested

Capital invested by funds: $82.5M → $0 (-$82.5M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 73

Holders
1
Holders Change
-73
Holders Change %
-98.65%
% of All Funds
0.01%
Holding in Top 10
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-100%
% of All Funds
New
Increased
1
Reduced
Closed
73
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
RC
26
Rangeley Capital
Connecticut
-$306K -153,790 Closed
State Street
27
State Street
Massachusetts
-$219K -110,264 Closed
YIH
28
Y-Intercept (HK)
Hong Kong
-$217K -109,153 Closed
ZIM
29
Zacks Investment Management
Illinois
-$185K -92,803 Closed
BCM
30
BML Capital Management
Indiana
-$183K -91,913 Closed
GCP
31
GSA Capital Partners
United Kingdom
-$156K -78,466 Closed
MCP
32
Militia Capital Partners
Nevada
-$142K -71,606 Closed
Northern Trust
33
Northern Trust
Illinois
-$124K -62,134 Closed
Squarepoint
34
Squarepoint
New York
-$123K -61,997 Closed
Dimensional Fund Advisors
35
Dimensional Fund Advisors
Texas
-$122K -61,542 Closed
Renaissance Technologies
36
Renaissance Technologies
New York
-$108K -54,100 Closed
Qube Research & Technologies (QRT)
37
Qube Research & Technologies (QRT)
United Kingdom
-$99.4K -49,963 Closed
AQR Capital Management
38
AQR Capital Management
Connecticut
-$86K -43,219 Closed
Verition Fund Management
39
Verition Fund Management
Connecticut
-$74.9K -37,625 Closed
UBS Group
40
UBS Group
Switzerland
-$68.3K -34,324 Closed
QC
41
Quadrature Capital
United Kingdom
-$61.6K -30,942 Closed
JG
42
Jain Global
New York
-$60.2K -30,257 Closed
Citadel Advisors
43
Citadel Advisors
Florida
-$60.1K -30,196 Closed
CSS
44
Cubist Systematic Strategies
Connecticut
-$52.7K -26,493 Closed
Federated Hermes
45
Federated Hermes
Pennsylvania
-$52.7K -26,467 Closed
Russell Investments Group
46
Russell Investments Group
United Kingdom
-$47.5K -23,939 Closed
PAS
47
Point72 Asia (Singapore)
Singapore
-$45.7K -22,986 Closed
Marshall Wace
48
Marshall Wace
United Kingdom
-$42.6K -21,400 Closed
Fidelity Investments
49
Fidelity Investments
Massachusetts
-$38.5K -19,331 Closed
American Century Companies
50
American Century Companies
Missouri
-$36.9K -18,565 Closed

HLVX Hedge Fund Activity: Q3 2025 in Review

1 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in HilleVax (HLVX) for Q3 2025, worth a combined $0 — down 100% from $82.5M a quarter earlier.

Sellers outnumbered buyers: 73 funds closed out of HLVX and 0 opened new positions — a net loss of 73 holders — while 0 trimmed existing stakes and 1 added.

The largest buyer was XTX Topco, adding an estimated $285K. The largest seller was Frazier Life Sciences Management, exiting entirely with an estimated $21.1M sold.

  • 1 institutional investor held HilleVax (HLVX) as of Q3 2025, down from 74 in Q2 2025.
  • Funds reported $0 of HilleVax stock for Q3 2025, down 100% quarter-over-quarter.
  • 0 funds opened new HilleVax positions in Q3 2025 and 73 closed out, a net change of -73 holders.
  • The largest HilleVax buyer in Q3 2025 was XTX Topco, an estimated $285K added.
  • The largest HilleVax seller in Q3 2025 was Frazier Life Sciences Management, an estimated $21.1M sold.

Based on aggregated 13F filings for Q3 2025.